SCHEDULE 13D
This Amendment No. 14 (“Amendment No. 14”), being filed jointly by CBI USA, Inc. (“CBI USA”) and DGP Co., Ltd. (“DGP”, and together with CBI USA, the “Reporting Persons”), amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on June 1, 2022 (the “Initial Schedule 13D” and together with Amendment No. 1 thereto filed with the SEC on October 31, 2022 (“Amendment No. 1”), Amendment No. 2 thereto filed with the SEC on December 5, 2022 (“Amendment No. 2”), Amendment No. 3 thereto filed with the SEC on December 19, 2022 (“Amendment No. 3”), Amendment No. 4 thereto filed with the SEC on January 23, 2023 (“Amendment No. 4”), Amendment No. 5 thereto filed with the SEC on February 13, 2023 (“Amendment No. 5”), Amendment No. 6 thereto filed with the SEC on March 3, 2023 (“Amendment No. 6”), Amendment No. 7 thereto filed with the SEC on May 1, 2023 (“Amendment No. 7”), Amendment No. 8 thereto filed with the SEC on May 17, 2023 (“Amendment No. 8”), Amendment No. 9 thereto filed with the SEC on June 28, 2023 (“Amendment No. 9”), Amendment No. 10 thereto filed with the SEC on August 8, 2023 (“Amendment No. 10”), Amendment No. 11 thereto filed with the SEC on March 4, 2024 (“Amendment No. 11”), Amendment No. 12 thereto filed with the SEC on July 2, 2024 (“Amendment No. 12”), and Amendment No. 13 thereto filed with the SEC on August 5, 2024 (“Amendment No. 13”), the “Schedule 13D”) by CBI USA, and, with respect to Amendment No. 9, Amendment No. 10, Amendment No. 11, Amendment No. 12, and Amendment No. 13, DGP, with respect to the Common Stock, par value $0.0001 per share, of Exicure, Inc. (“Exicure” or the “Company”). This Amendment No. 14 amends Items 5 and 6 to the extent set forth below.
Item 5. Interest in Securities of the Issuer
Item 5 is supplemented as follows:
On September 12, 2024, in connection with the Debt-for-Equity Exchange (as reported in Item 6), DGP agreed to exchange the DGP Note for 237,233 shares of its common stock. As a result, as of September 12, 2024, DGP beneficially owns (with sole voting power) 849,223 shares of Common Stock representing 39.1% of the outstanding shares of Common Stock, and CBI USA beneficially owns (with sole voting and dispositive power) 163,660 shares of Common Stock representing 7.5% of the outstanding shares of Common Stock. The Reporting Persons as a group beneficially own 46.6% of the outstanding shares of Common Stock as of such date. The percentage ownerships are based on 2,172,323 shares outstanding (representing 1,833,109 shares outstanding as of September 9, 2024, as reported by the Company’s transfer agent, plus 339,214 shares that the Company agreed to issue pursuant to those certain debt-for-equity equity exchange agreements dated September 12, 2024 as reported in the Form 8-K filed by the Company on September 13, 2024).
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
Item 6 is supplemented as follows: